COX6CP13

Across TCGA pan-cancer cohorts, COX6CP13 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of COX6CP13’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where COX6CP13 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types COX6CP13 is over-expressed in tumor, although a few such as PRAD show the opposite, repressed pattern.

KIRC, PRAD, and BRCA are the cancer types where COX6CP13 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in COX6CP13 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.130	.005	6	view →
PRAD	All	All	−0.127	.003	2	view →
BRCA	Female	All	+0.089	.040	2	view →
LUAD	Male	All	+0.278	.045	1	view →
KICH	Female	II,III,IV	+0.151	.029	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

COX6CP13–KIRC

Open the KIRC breakdown →